Ratovitski E A, Kotzbauer P T, Milbrandt J, Lowenstein C J, Burrow C R
Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
J Biol Chem. 1998 Feb 6;273(6):3654-60. doi: 10.1074/jbc.273.6.3654.
The G401 cell line derived from a rhabdoid tumor of the kidney secretes the heparin-binding growth factors midkine and pleiotrophin. Both proteins act as mitogens for diverse cells, but only midkine serves as an autocrine mitogen for G401 tumor cells. We show that midkine specifically binds a protein or complex of molecular mass greater than 200 kDa with high affinity (Kd = 0.07 +/- 0.01 nM). Midkine, but not pleiotrophin, stimulates tyrosine phosphorylation of several cellular proteins with molecular mass of 100, 130, and 200+ kDa. Upon midkine binding, the midkine-receptor complex associates with the Janus tyrosine kinases, JAK1 and JAK2. MK stimulates tyrosine phosphorylation of JAK1, JAK2, and STAT1alpha. Our initial characterization of the midkine receptor suggests that midkine autocrine stimulation of tumor cell proliferation is mediated by a cell-surface receptor which in turn might activate the JAK/STAT pathway.
源自肾横纹肌样瘤的G401细胞系分泌肝素结合生长因子中期因子和多效生长因子。这两种蛋白均作为多种细胞的促有丝分裂原,但只有中期因子作为G401肿瘤细胞的自分泌促有丝分裂原。我们发现中期因子能以高亲和力(Kd = 0.07 +/- 0.01 nM)特异性结合一种分子量大于200 kDa的蛋白质或复合物。中期因子而非多效生长因子能刺激几种分子量为100、130和200 kDa以上的细胞蛋白发生酪氨酸磷酸化。中期因子结合后,中期因子-受体复合物与Janus酪氨酸激酶JAK1和JAK2结合。中期因子刺激JAK1、JAK2和STAT1α的酪氨酸磷酸化。我们对中期因子受体的初步表征表明,中期因子对肿瘤细胞增殖的自分泌刺激是由一种细胞表面受体介导的,该受体进而可能激活JAK/STAT途径。